Information:
Fel:
ID
28776
Beskrivning
Trial of Lycopene/Ateronon for Secondary Prevention of Coronary Heart Disease; ODM derived from: https://clinicaltrials.gov/show/NCT00939237
Länk
https://clinicaltrials.gov/show/NCT00939237
Nyckelord
Versioner (1)
- 2018-02-03 2018-02-03 -
Rättsinnehavare
See clinicaltrials.gov
Uppladdad den
3 februari 2018
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Coronary Heart Disease NCT00939237
Eligibility Coronary Heart Disease NCT00939237
- StudyEvent: Eligibility
Similar models
Eligibility Coronary Heart Disease NCT00939237
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Coronary heart disease
Item
brigham and women's hospital cardiology clinic patients with history of coronary heart disease occurring at least 6 months ago:
boolean
C0010068 (UMLS CUI [1])
Myocardial Infarction
Item
history of myocardial infarction (mi) confirmed by medical records and/or
boolean
C0027051 (UMLS CUI [1])
Percutaneous Coronary Intervention | Coronary Artery Bypass Surgery
Item
history of percutaneous coronary intervention (pci) or coronary artery bypass surgery (cabg)
boolean
C1532338 (UMLS CUI [1])
C0010055 (UMLS CUI [2])
C0010055 (UMLS CUI [2])
Protocol Compliance | Intake Investigational New Drugs Percentage
Item
compliance during run-in as demonstrated by taking at least 66% of study medications
boolean
C0525058 (UMLS CUI [1])
C1512806 (UMLS CUI [2,1])
C0013230 (UMLS CUI [2,2])
C0439165 (UMLS CUI [2,3])
C1512806 (UMLS CUI [2,1])
C0013230 (UMLS CUI [2,2])
C0439165 (UMLS CUI [2,3])
Questionnaires Completion | Medical History | Pharmaceutical Preparations Use of | Coronary heart disease Risk factors | Adverse event potential | Diet
Item
ability and willingness to complete questionnaires concerning medical history, concomitant medication use, coronary heart disease risk factors, potential adverse events, and diet
boolean
C0034394 (UMLS CUI [1,1])
C0205197 (UMLS CUI [1,2])
C0262926 (UMLS CUI [2])
C0013227 (UMLS CUI [3,1])
C1524063 (UMLS CUI [3,2])
C0010068 (UMLS CUI [4,1])
C0035648 (UMLS CUI [4,2])
C0877248 (UMLS CUI [5,1])
C3245505 (UMLS CUI [5,2])
C0012155 (UMLS CUI [6])
C0205197 (UMLS CUI [1,2])
C0262926 (UMLS CUI [2])
C0013227 (UMLS CUI [3,1])
C1524063 (UMLS CUI [3,2])
C0010068 (UMLS CUI [4,1])
C0035648 (UMLS CUI [4,2])
C0877248 (UMLS CUI [5,1])
C3245505 (UMLS CUI [5,2])
C0012155 (UMLS CUI [6])
Carotid stent | Carotid Endarterectomy | Carotid surgery
Item
history of carotid stent, carotid endarterectomy, or carotid artery surgery
boolean
C0850458 (UMLS CUI [1])
C0014099 (UMLS CUI [2])
C0741984 (UMLS CUI [3])
C0014099 (UMLS CUI [2])
C0741984 (UMLS CUI [3])
Congestive heart failure New York Heart Association Classification
Item
history of diagnosed congestive heart failure meeting new york association functional classification iii or iv criteria
boolean
C0018802 (UMLS CUI [1,1])
C1275491 (UMLS CUI [1,2])
C1275491 (UMLS CUI [1,2])
Statin Use of Initiation | Statin Use of Change | Lipid-lowering therapy Initiation | Lipid-lowering therapy Change
Item
any initiation or change in statin use or other lipid-lowering treatment within 3 months of randomization
boolean
C0360714 (UMLS CUI [1,1])
C1524063 (UMLS CUI [1,2])
C1704686 (UMLS CUI [1,3])
C0360714 (UMLS CUI [2,1])
C1524063 (UMLS CUI [2,2])
C0392747 (UMLS CUI [2,3])
C0585943 (UMLS CUI [3,1])
C1704686 (UMLS CUI [3,2])
C0585943 (UMLS CUI [4,1])
C0392747 (UMLS CUI [4,2])
C1524063 (UMLS CUI [1,2])
C1704686 (UMLS CUI [1,3])
C0360714 (UMLS CUI [2,1])
C1524063 (UMLS CUI [2,2])
C0392747 (UMLS CUI [2,3])
C0585943 (UMLS CUI [3,1])
C1704686 (UMLS CUI [3,2])
C0585943 (UMLS CUI [4,1])
C0392747 (UMLS CUI [4,2])
Lactose Intolerance
Item
lactose intolerance
boolean
C0022951 (UMLS CUI [1])
Hypersensitivity Whey Proteins
Item
allergies to whey protein
boolean
C0020517 (UMLS CUI [1,1])
C0078479 (UMLS CUI [1,2])
C0078479 (UMLS CUI [1,2])
Allergy to soy protein products
Item
allergies to soy protein
boolean
C2136331 (UMLS CUI [1])
Malignant Neoplasms | Exception Skin carcinoma
Item
history of active cancer diagnosis (except non-melanoma skin cancer) within last 3 years
boolean
C0006826 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0699893 (UMLS CUI [2,2])
C1705847 (UMLS CUI [2,1])
C0699893 (UMLS CUI [2,2])
Life Expectancy
Item
life expectancy < 1 year
boolean
C0023671 (UMLS CUI [1])
Pregnancy | Breast Feeding | Pregnancy, Planned
Item
women who are pregnant, nursing, or intend pregnancy during the period of treatment
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0032992 (UMLS CUI [3])
C0006147 (UMLS CUI [2])
C0032992 (UMLS CUI [3])
Relocation of home Planned
Item
plan to relocate out of boston area within the next year
boolean
C2699029 (UMLS CUI [1,1])
C1301732 (UMLS CUI [1,2])
C1301732 (UMLS CUI [1,2])
Informed Consent Unable
Item
inability to provide informed consent
boolean
C0021430 (UMLS CUI [1,1])
C1299582 (UMLS CUI [1,2])
C1299582 (UMLS CUI [1,2])
Carotid artery occlusion | Carotid artery dissection | Carotid Intima-Media Thickness
Item
carotid artery occlusion or dissection at baseline carotid imt assessment
boolean
C0265101 (UMLS CUI [1])
C0338585 (UMLS CUI [2])
C1960466 (UMLS CUI [3])
C0338585 (UMLS CUI [2])
C1960466 (UMLS CUI [3])